drug development

There Go Those Drug Companies Inventing New Diseases Again
There Go Those Drug Companies Inventing New Diseases Again
Forbes
drug development
Flag link:
Vertex doubles size of cystic fibrosis drug discovery site
Vertex doubles size of cystic fibrosis drug discovery site
Fierce Biotech
Vertex Pharmaceuticals
R&D
drug development
cystic fibrosis
Flag link:
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
Harvard Business Week
innovation
drug development
Flag link:
FDA Chief Proposes New Pricing Model and Cites New Guidelines to Spur Antibiotic Development
FDA Chief Proposes New Pricing Model and Cites New Guidelines to Spur Antibiotic Development
CP Wire
FDA
Scott Gottlieb
antibiotic resistance
drug development
bacteriophage
Flag link:
'Patient-focused' drug development guidance coming, FDA chief says
'Patient-focused' drug development guidance coming, FDA chief says
Biopharma Dive
FDA
patients
drug development
Scott Gottlieb
Flag link:
Pharma R&D Investments Moderating -- But Still High
Pharma R&D Investments Moderating -- But Still High
Forbes
R&D
drug development
Flag link:
Bill And Melinda Gates Start A Nonprofit Biotech In Boston
Bill And Melinda Gates Start A Nonprofit Biotech In Boston
Forbes
biotech
Bill Gates
Gates Foundation
non-profits
Boston
drug development
Flag link:
Gilead, Hookipa pen hepatitis B, HIV research collaboration
Gilead, Hookipa pen hepatitis B, HIV research collaboration
Fierce Biotech
Gilead Sciences
Hookipa
hepatitis B
HIV
vaccines
drug development
Flag link:
FDA Proposes Process Modernization to Support New Drug Development
FDA Proposes Process Modernization to Support New Drug Development
FDA Voice
FDA
CDER
drug development
process modernization
Flag link:
Amgen to ramp up early-stage immuno-oncology with 2 MD Anderson deals
Amgen to ramp up early-stage immuno-oncology with 2 MD Anderson deals
Fierce Biotech
Amgen
MD Anderson Cancer Center
drug development
blood cancers
Small-Cell Lung Cancer
Flag link:
Study says pharma mergers result in fewer new medicines
Study says pharma mergers result in fewer new medicines
Axios
M&A
drug development
Flag link:
Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities
Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities
Biosimilar Development
Amgen
Avalere
biosimilars
drug development
payers
Flag link:
Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk
Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk
Medical Marketing and Media
Robert Califf
drug development
Flag link:
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Fierce Biotech
Roche
NewLink Genetics
IDO/TDO inhibitors
drug development
Flag link:
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
CP Wire
Alzheimer's disease
dementia
drug development
Australia
Flag link:
Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
CP Wire
Exelixis
Invenra
cancer
Merck
drug development
Flag link:
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge
Xconomy
FluGen
drug development
universal flu vaccine
Bill Gates
Flag link:
La Jolla's Synthorx raises $63 million to make cancer drugs from bacterium with artificial DNA
La Jolla's Synthorx raises $63 million to make cancer drugs from bacterium with artificial DNA
San Diego Union Tribune, CA
Synthorx
drug development
Flag link:
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Forbes
Biogen
Ionis Pharmaceuticals
drug development
R&D
Flag link:
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
Endpoints
FDA
Scott Gottlieb
drug development
Flag link:

Pages